Form D · Pharmaceuticals
TP Therapeutics, Inc.
San Diego, CA · CIK 0001669759
Offering snapshot reported Mar 21, 2016 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2016 | Initial | $17,979,732 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259624
Source: Form D, filed Mar 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bihua Chen | Director |
| Jingrong Jean Cui | Director, Executive |
| Kenneth Fong | Director |
| George J. Lee | Director |
| Yishan Li | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6650 Lusk Blvd. Suite B107
San Diego, CA, 92121
San Diego, CA, 92121